Carriage Services Declares Quarterly Cash Dividend

HOUSTON, Jan. 16, 2025 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) today announced that its Board of Directors on January 16, 2025 declared a quarterly dividend of 11.25¢ per share payable on March 3, 2025 to common share record holders as of February 3, 2025. 

Carriage Services is a leading provider of funeral and cemetery services and merchandise in the United States. Carriage Services operates 162 funeral homes in 26 states and 31 cemeteries in 11 states.  It is dedicated to delivering premier experiences through innovation, partnership, and elevated service.

For more information, please email [email protected].



Globe Life Inc. AnnouncesFourth Quarter 2024 Earnings Release and Conference Call

PR Newswire


MCKINNEY, Texas
, Jan. 16, 2025 /PRNewswire/ — Globe Life Inc. (NYSE: GL) will announce its Fourth Quarter 2024 financial results after the market closes on Wednesday, February 5, 2025. At that time, a copy of the Company’s Fourth Quarter 2024 earnings press release and any other financial and statistical information about the quarter will be available on the Company’s website, https://investors.globelifeinsurance.com/, under Financial Reports and Other Financial Information.

A live conference call will broadcast on Thursday,
February 6, 2025, at 11:00am Eastern (10:00am Central)


at 1-786-697-3501 (passcode: Globe Life Inc.)
or online under Calls and Meetings at: https://investors.globelifeinsurance.com/

You can also hear a replay of the conference call by using the same link above.

Globe Life Inc. is a holding company specializing in life and supplemental health insurance for the middle-income market distributed through multiple channels, including direct to consumer and exclusive and independent agencies.

Cision View original content:https://www.prnewswire.com/news-releases/globe-life-inc-announces-fourth-quarter-2024-earnings-release-and-conference-call-302353733.html

SOURCE Globe Life Inc.

Adams Diversified Equity Fund Announces 2024 Performance

BALTIMORE, Jan. 16, 2025 (GLOBE NEWSWIRE) — Adams Diversified Equity Fund, Inc. (NYSE: ADX) announces the Fund’s investment returns for 2024. The total return on the Fund’s net asset value for 2024 was 23.6%, with dividends and capital gains reinvested. The comparable figures for the S&P 500 Index and Morningstar U.S. Large Blend Category were 25.0% and 22.7%, respectively. The total return on the Fund’s market price for the period was 28.1%.

The Fund paid $2.50 per share in income dividends and realized capital gain distributions to shareholders in 2024, producing an annual distribution rate of 10.9% on net asset value.

“In a year of increased volatility related to the presidential election, we were pleased to outperform our peers in 2024 and distribute 10.9% of NAV to shareholders, significantly more than our new commitment adopted mid-year to annually distribute 8% of NAV,” said Jim Haynie, CEO of Adams Funds.

The 2024 Annual Report is expected to be released on or about February 19, 2025.

 
ANNUALIZED ONE, THREE, FIVE, AND TEN-YEAR COMPARATIVE RETURNS (12/31/24)
 
  1 Year 3 Year 5 Year 10 Year
Adams Diversified Equity Fund  (NAV) 23.6 % 9.2 % 15.0 % 13.7 %
Adams Diversified Equity Fund (market price) 28.1 % 10.5 % 15.3 % 14.1 %
Morningstar U.S. Large Blend Category 22.7 % 7.8 % 13.3 % 11.8 %
S&P 500 25.0 % 8.9 % 14.5 % 13.1 %
                 

NET ASSET VALUE ANNOUNCED

The Fund’s net asset value at the end of 2024, compared with the year earlier, was:

  12/31/24 12/31/23
Net assets $ 2,662,523,552 $ 2,550,393,350
Shares outstanding 117,585,976 124,051,639
Net asset value per share $ 22.64 $ 20.56
     

TEN LARGEST EQUITY PORTFOLIO HOLDINGS (12/31/24)
 
  % of Net Assets
Apple Inc. 8.0 %
Microsoft Corporation.  7.1 %
NVIDIA Corporation 6.9 %
Amazon.com, Inc. 4.8 %
Alphabet Inc. Class A 3.9 %
Meta Platforms, Inc. Class A 2.8 %
Broadcom Inc. 2.5 %
Adams Natural Resources Fund, Inc.* 1.9 %
JP Morgan Chase & Co. 1.9 %
Tesla, Inc. 1.8 %
     Total 41.6 %
* Non-controlled affiliated closed-end fund.    
     

SECTOR WEIGHTINGS (12/31/24)
 
  % of Net Assets
Information Technology 32.4 %
Financials 13.4 %
Consumer Discretionary 11.4 %
Health Care 9.9 %
Communication Services 9.3 %
Industrials 7.8 %
Consumer Staples 5.7 %
Energy 3.5 %
Utilities 2.2 %
Real Estate 2.0 %
Materials 1.7 %
     

About Adams Funds

Since 1929, Adams Funds has consistently helped generations of investors reach their investment goals. Adams Funds is comprised of two closed-end funds, Adams Diversified Equity Fund, Inc. (NYSE: ADX) and Adams Natural Resources Fund, Inc. (NYSE: PEO). The Funds are actively managed by an experienced team with a disciplined approach and have paid dividends for more than 90 years across many market cycles. The Funds are committed to paying a minimum annual distribution rate of 8% of NAV paid evenly each quarter throughout the year, providing reliability for long-term shareholders. A portion of any distribution may be treated as paid from sources other than net income, including but not limited to short-term capital gain, long-term capital gain, and return of capital. The final determination of the source of all distributions for tax reporting purposes in a calendar year, including the percentage of qualified dividend income, will be made after year-end. Shares can be purchased through our transfer agent or through a broker. For more information about Adams Funds, please visit: adamsfunds.com.

For further information please contact: adamsfunds.com/about/contact │800.638.2479



AGCO ANNOUNCES QUARTERLY DIVIDEND

PR Newswire


DULUTH, Ga.
, Jan. 16, 2025 /PRNewswire/ — AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, announced today its Board of Directors declared a regular quarterly dividend of $0.29 per common share to be paid on March 14, 2025, to all stockholders of record as of the close of business February 14, 2025.

About AGCO
AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology. AGCO delivers value to farmers and OEM customers through its differentiated brand portfolio, including leading brands Fendt®, Massey Ferguson®, PTx and Valtra®. AGCO’s full line of equipment, smart farming solutions and services helps farmers sustainably feed our world. Founded in 1990 and headquartered in Duluth, Georgia, USA, AGCO had net sales of approximately $14.4 billion in 2023. For more information, visit www.agcocorp.com.

Please visit our website at www.agcocorp.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/agco-announces-quarterly-dividend-302353730.html

SOURCE AGCO Corporation

Adams Natural Resources Fund Announces 2024 Performance

BALTIMORE, Jan. 16, 2025 (GLOBE NEWSWIRE) — Adams Natural Resources Fund, Inc. (NYSE: PEO) announces the Fund’s investment returns for 2024. The total return on the Fund’s net asset value for 2024 was 5.3%, with dividends and capital gains reinvested. The comparable figures for the S&P 500 Energy Sector and the S&P 500 Materials Sector were 5.7% and 0.0%, respectively.  Our benchmark, which is comprised of the S&P 500 Energy Sector (80%) and the S&P 500 Materials Sector (20%), returned 4.6%. The total return on the Fund’s market price for the same period was 13.8%.

The Fund paid $1.77 per share in income dividends and realized capital gain distributions to shareholders in 2024, producing an annual distribution rate of 6.7% of net asset value.

“The Energy market presented challenges in 2024. Our disciplined approach supported good stock selection that enabled the Fund to outperform its benchmark,” said Jim Haynie, CEO of Adams Funds. 

The 2024 Annual Report is expected to be released on or about February 19, 2025.

ANNUALIZED ONE, THREE, FIVE, AND TEN-YEAR COMPARATIVE RETURNS (12/31/24)
         
  1 Year 3 Year 5 Year 10 Year
Adams Natural Resources Fund (NAV) 5.3% 16.1% 12.5% 5.5%
Adams Natural Resources Fund (market price) 13.8% 17.8% 13.0% 5.8%
S&P 500 Energy Sector 5.7% 20.0% 12.1% 4.9%
S&P 500 Materials Sector 0.0% -0.4% 8.7% 7.9%
         

NET ASSET VALUE ANNOUNCED

The Fund’s net asset value at the end of 2024, compared with the year earlier, was:

  12/31/24 12/31/23
Net assets $636,334,398 $633,446,941
Shares outstanding 26,284,550 25,514,441
Net asset value per share $24.21 $24.83
     

 TEN LARGEST EQUITY PORTFOLIO HOLDINGS (12/31/24)
   
  % of Net Assets
Exxon Mobil Corporation 24.2%
Chevron Corporation 11.6%
ConocoPhillips 6.4%
Linde plc 4.6%
EOG Resources, Inc. 4.2%
Williams Companies, Inc.. 3.1%
ONEOK, Inc. 3.0%
Hess Corporation 2.9%
Baker Hughes Company 2.8%
Phillips 66 2.5%
     Total 65.3%
   

INDUSTRY WEIGHTINGS (12/31/24)
   
  % of Net Assets
Energy  
Integrated Oil & Gas 35.8%
Exploration & Production 20.7%
Storage & Transportation 10.3%
Refining & Marketing 6.4%
Equipment & Services 6.3%
Energy Related 0.5%
Materials  
Chemicals 13.0%
Metals & Mining   3.1%
Containers & Packaging 1.9%
Construction Materials 1.5%
   

About Adams Funds

Since 1929, Adams Funds has consistently helped generations of investors reach their investment goals. Adams Funds is comprised of two closed-end funds, Adams Diversified Equity Fund, Inc. (NYSE: ADX) and Adams Natural Resources Fund, Inc. (NYSE: PEO). The Funds are actively managed by an experienced team with a disciplined approach and have paid dividends for more than 90 years across many market cycles. The Funds are committed to paying a minimum annual distribution rate of 8% of NAV paid evenly each quarter throughout the year, providing reliability for long-term shareholders. A portion of any distribution may be treated as paid from sources other than net income, including but not limited to short-term capital gain, long-term capital gain, and return of capital. The final determination of the source of all distributions for tax reporting purposes in a calendar year, including the percentage of qualified dividend income, will be made after year-end. Shares can be purchased through our transfer agent or through a broker. For more information about Adams Funds, please visit: adamsfunds.com.

For further information please contact: adamsfunds.com/about/contact │800.638.2479 



Community Healthcare Trust Announces Fourth Quarter Earnings Release Date And Conference Call

PR Newswire


FRANKLIN, Tenn.
, Jan. 16, 2025 /PRNewswire/ — Community Healthcare Trust Incorporated (NYSE: CHCT) today announced that on Tuesday evening, February 18, 2025, after the market closes, it will report results for the fourth quarter of 2024. 

On February 19, 2025, at 9:00 a.m. Central Time, Community Healthcare Trust will hold a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends. Simultaneously, a webcast of the conference call will be available to interested parties via an Internet link at www.chct.reit under the Investor Relations section. A webcast replay will be available following the call at the same Internet site address.

Conference Call Details

Domestic Dial-In Number: 1-888-347-1332

International Dial-In Number: 1-412-902-4278

Canada Toll Free: 1-855-669-9657

Replay Conference Call Details

Domestic Dial-In Number: 1-877-344-7529

International Dial-In Number: 1-412-317-0088

Canada Toll Free: 1-855-669-9658

Conference ID: 6215437

About Community Healthcare Trust Incorporated

Community Healthcare Trust Incorporated (the “Company”) is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of September 30, 2024, the Company had investments of approximately $1.1 billion in 198 real estate properties (including a portion of one property accounted for as a sales-type lease and one property classified as held for sale). The properties are located in 35 states, totaling approximately 4.4 million square feet in the aggregate.


Cautionary Note Regarding Forward-Looking Statements

In addition to the historical information contained within, the matters discussed in this press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “believes”, “expects”, “may”, “will,” “should”, “seeks”, “approximately”, “intends”, “plans”, “estimates”, “anticipates” or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the control of Community Healthcare Trust Incorporated (the “Company”). Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, changes in governmental regulations, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract, catastrophic or extreme weather and other natural events and the physical effects of climate change, the occurrence of cyber incidents, effects on global and national markets as well as businesses resulting from increased inflation, rising interest rates, supply chain disruptions, labor conditions, and/or the conflicts in Ukraine and the Middle East, and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this press release and undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.

CONTACT: Bill Monroe, 615-771-3052

Cision View original content:https://www.prnewswire.com/news-releases/community-healthcare-trust-announces-fourth-quarter-earnings-release-date-and-conference-call-302353715.html

SOURCE Community Healthcare Trust Incorporated

WaFd Announces Quarterly Earnings Per Share of $0.54

WaFd Announces Quarterly Earnings Per Share of $0.54

SEATTLE–(BUSINESS WIRE)–
WaFd, Inc. (Nasdaq: WAFD): 

Q1 Highlights

$47 Million

 

 

$0.54

 

 

0.69%

 

 

6.42%

Net Income

 

 

Diluted Earnings per

Common Share

 

 

Return on Average

Assets

 

 

Return on Average

Common Equity

 

 

Net Interest Income and NIM

  • $155 million net interest income for the quarter compared to $173 million in Q4 FY24.
  • Net interest margin at 2.39% for the quarter compared to 2.62% for Q4 FY24.

 

Credit Quality

  • Non-performing assets at 0.3% of total assets – similar to prior quarter.
  • No provision booked for the quarter and NCOs were minimal.

 

 

 

 

 

Non-Interest Income and Expense

  • Non-interest expense up due to $5.4 million in one-time restructuring charges, partially offset by lower FDIC insurance premiums due to a smaller balance sheet.

 

Shareholder Returns and Stock Activity

  • On December 6, 2024, the Company paid a cash dividend of $0.26 per share, 167th consecutive quarterly dividend paid.

 

 

WaFd, Inc. (Nasdaq: WAFD) (the “Company”), parent company of Washington Federal Bank (“WaFd Bank” or the “Bank”), today announced quarterly earnings of $47,267,000 for the quarter ended December 31, 2024, a decrease of 23% from net earnings of $61,140,000 for the quarter ended September 30, 2024 and a decrease of 19% from net earnings of $58,453,000 for the quarter ended December 31, 2023. After the effect of dividends on preferred stock, net income available for common shareholders was $0.54 per diluted share for the quarter ended December 31, 2024, compared to $0.71 per diluted share for the quarter ended September 30, 2024, a $0.17 or 24% decrease, and $0.85 per diluted share for the quarter ended December 31, 2023, a $0.31 or 36% decrease in fully diluted earnings per common share. The current quarter results reflect one-time charges of $5,390,000 as a result of restructuring activities described below. After adjusting for these charges and other non-operating items, earnings per share for the quarter was $0.62 per diluted share. For a reconciliation, see the Non-GAAP Financial Measures section below.

“In the first quarter of fiscal 2025 our results were impacted by greater than expected margin compression. On a linked quarter basis our margin contracted from 2.62% to 2.39%. Excluding a valuation adjustment to hedges obtained in the Luther Burbank acquisition, the Q1 margin would have been 2.45%. The Federal Reserve started reducing interest rates with a 50 basis point cut on September 18, 2024, followed by two 25 basis point cuts in October and December. With each cut, our variable rate assets (loans and investments) repriced quickly, while the repricing of our liabilities has lagged, causing margin compression. On a linked quarter basis, the yield on earning assets declined by 36 basis points, while the yield on paying liabilities decreased by only 14 basis points. We are pleased to report that credit quality remains strong with minimal net charge-offs and delinquencies of only 0.30%. Capital has grown nicely over the last three quarters, with tangible common equity to tangible assets increasing from 8.31% to 9.45% since our acquisition in March of last year.

Today we are announcing a significant shift in focus for our business model. After over 100 years of making home loans, we are exiting the single-family mortgage lending market and have recorded a restructuring expense of $5.4 million this quarter. As a result, by the end of June 2025, we anticipate annual expense savings of approximately $17 million. Importantly, we will retain all existing home loans and HELOC’s on our books, ensuring no disruption for our current customers. We have come to this conclusion after thoughtful deliberation for two primary reasons. First, home loans are seen as a commodity with nearly 70% of originations sold to US government sponsored enterprises like Freddie Mac and Fannie Mae, which has caused profitability to decrease and credit risk to increase. Second, technology has made it easy for consumers to refinance (which is a good thing for homeowners), but it increases the interest rate risk for banks that hold mortgages. Our aim is to always offer products and services to our customers where WaFd Bank can add value, and we have concluded that we no longer do so in the mortgage sector. Exiting mortgage lending and right sizing other support areas will result in an 8% reduction in our workforce.

While not the primary factor, but certainly a contributing factor, the regulatory burden associated with mortgage lending also played a role in our decision. Recently we were notified that WaFd Bank has received an overall “Needs to Improve” rating regarding our Community Reinvestment Act (“CRA”) compliance because we did not make enough loans to low and moderate income (“LMI”) borrowers and communities. For the individual components of the exam, we received a “High Satisfactory” rating in both the investment and service tests, and a “Needs to Improve” on the lending test. We are committed to serving all of our communities and have done so as a portfolio lender since 1917. Today, we compete against government-sponsored financing programs with less stringent underwriting than we are comfortable offering as a lender that retains all loans on our balance sheet. For example, there are multiple government programs that require no down payment, and our performance is being compared to lenders who offer these programs and originate to sell. We strongly disagree with this rating and plan to appeal this conclusion.

Through our involvement in the PPP program during the Pandemic, we have seen just how important small business is to us, and to the communities we serve, and how underserved many small businesses are when it comes to their banking needs. Technology is excellent and abundant; what small businesses need is a trusted advisor to help them navigate complex financial matters and exercise professional skepticism. We aim to fill that need. Going forward, in addition to serving consumers, WaFd will concentrate its focus, offerings and efforts on business banking and commercial real estate lending. We will also begin offering SBA lending products that will allow us to broaden our offerings for small businesses.

We have also re-aligned our management structure. On the executive team, Cathy Cooper will transition to the role of Chief Experience Officer, responsible for enhancing overall client experience through digital channels and in person processes. James Endrizzi will step aside from his current role and will assume leadership responsibility for Commercial Real Estate in both Utah and Nevada in a non-executive role. The Business Bank Division will be led by Michelle Coons, Dan LaCoste and Doron Joseph. The Commercial Real Estate Division will be led by Tony Barnard and Tom Pozarycki. All five of these leaders have been promoted to the role of Executive Director but are not deemed executive officers under SEC rules.

Here at WaFd, we strive to be a bank with heart. That does not mean we ignore issues or avoid difficult decisions. We firmly believe the actions being announced today will position us to better serve our clients and deliver solid returns to our shareholders for years to come.”

Brent Beardall

President and CEO of WaFd Bank

 

 

 

 

 

The Company acquired Luther Burbank Corporation (“LBC”) on February 29, 2024. As such, the Company’s financial results are not directly comparable to the results of periods prior to that date. The following table provides the Company’s financial scorecard for the last five quarters:

 

As of

(In thousands, except share and ratio data)

December 31,|

2024

 

September 30,

2024

 

June 30,

2024

 

March 31,

2024

 

December 31,

2023

BALANCE SHEET

 

Cash

$

1,507,735

 

 

$

2,381,102

 

 

$

2,492,504

 

 

$

1,505,771

 

 

$

1,144,774

 

Loans receivable, net

 

21,060,501

 

 

 

20,916,354

 

 

 

20,873,919

 

 

 

20,795,259

 

 

 

17,584,622

 

Allowance for credit losses (“ACL”)

 

225,022

 

 

 

225,253

 

 

 

225,324

 

 

 

225,077

 

 

 

201,820

 

Loans held for sale

 

 

 

 

 

 

 

468,527

 

 

 

2,993,658

 

 

 

 

Available-for-sale securities, at fair value

 

2,743,731

 

 

 

2,572,709

 

 

 

2,428,768

 

 

 

2,438,114

 

 

 

2,018,445

 

Held-to-maturity securities, at amortized cost

 

537,348

 

 

 

436,972

 

 

 

447,638

 

 

 

457,882

 

 

 

415,079

 

Total investments

 

3,281,079

 

 

 

3,009,681

 

 

 

2,876,406

 

 

 

2,895,996

 

 

 

2,433,524

 

Total assets

 

27,684,454

 

 

 

28,060,330

 

 

 

28,580,800

 

 

 

30,140,288

 

 

 

22,640,122

 

Transaction deposits

 

11,853,859

 

 

 

11,817,185

 

 

 

11,929,005

 

 

 

12,338,862

 

 

 

10,658,064

 

Time deposits

 

9,584,918

 

 

 

9,556,785

 

 

 

9,255,760

 

 

 

9,000,911

 

 

 

5,380,723

 

Total deposits

 

21,438,777

 

 

 

21,373,970

 

 

 

21,184,765

 

 

 

21,339,773

 

 

 

16,038,787

 

Borrowings

 

2,914,627

 

 

 

3,318,307

 

 

 

4,079,360

 

 

 

5,489,501

 

 

 

3,875,000

 

Total shareholders’ equity

 

3,021,636

 

 

 

3,000,300

 

 

 

2,958,339

 

 

 

2,921,906

 

 

 

2,452,004

 

Loans to customer deposits2

 

98.24

%

 

 

97.86

%

 

 

98.53

%

 

 

97.45

%

 

 

109.64

%

 

 

 

 

 

 

 

 

 

 

PROFITABILITY

 

 

 

 

 

 

 

 

 

Net income

$

47,267

 

 

$

61,140

 

 

$

64,560

 

 

$

15,888

 

 

$

58,453

 

Net income to common shareholders

 

43,611

 

 

 

57,484

 

 

 

60,904

 

 

 

12,232

 

 

 

54,797

 

Earnings per common share

 

0.54

 

 

 

0.71

 

 

 

0.75

 

 

 

0.17

 

 

 

0.85

 

Return on tangible common equity1

 

7.69

%

 

 

10.24

%

 

 

11.10

%

 

 

2.47

%

 

 

11.93

%

Return on tangible assets1

 

0.70

%

 

 

0.89

%

 

 

0.88

%

 

 

0.26

%

 

 

1.06

%

Net interest margin

 

2.39

%

 

 

2.62

%

 

 

2.56

%

 

 

2.73

%

 

 

2.91

%

Efficiency ratio

 

65.04

%

 

 

57.21

%

 

 

56.61

%

 

 

77.74

%

 

 

58.02

%

 

 

 

 

 

 

 

 

 

 

FINANCIAL HIGHLIGHTS

 

 

 

 

 

 

 

 

 

Common shareholders’ equity per share

$

33.45

 

 

$

33.25

 

 

$

32.76

 

 

$

32.21

 

 

$

33.49

 

Tangible common shareholders’ equity per share1

 

27.93

 

 

 

27.73

 

 

 

27.18

 

 

 

26.64

 

 

 

28.65

 

Shareholders’ equity to total assets

 

10.91

%

 

 

10.69

%

 

 

10.35

%

 

 

9.69

%

 

 

10.83

%

Tangible shareholders’ equity to tangible assets1

 

9.45

%

 

 

9.24

%

 

 

8.91

%

 

 

8.31

%

 

 

9.59

%

Common shares outstanding

 

81,373,760

 

 

 

81,220,269

 

 

 

81,157,173

 

 

 

81,405,391

 

 

 

64,254,700

 

Preferred shares outstanding

 

300,000

 

 

 

300,000

 

 

 

300,000

 

 

 

300,000

 

 

 

300,000

 

 

 

 

 

 

 

 

 

 

 

CREDIT QUALITY2

 

 

 

 

 

 

 

 

 

ACL to gross loans

 

1.00

%

 

 

1.01

%

 

 

1.00

%

 

 

1.00

%

 

 

1.04

%

Non-accrual loans to net loans

 

0.34

%

 

 

0.33

%

 

 

0.29

%

 

 

0.29

%

 

 

0.26

%

Delinquencies to net loans

 

0.30

%

 

 

0.25

%

 

 

0.22

%

 

 

0.36

%

 

 

0.33

%

Non-performing assets to total assets

 

0.29

%

 

 

0.28

%

 

 

0.24

%

 

 

0.23

%

 

 

0.24

%

Criticized loans to net loans

 

2.54

%

 

 

2.41

%

 

 

3.01

%

 

 

2.59

%

 

 

2.27

%

Substandard loans to net loans

 

1.96

%

 

 

2.04

%

 

 

1.84

%

 

 

1.48

%

 

 

1.74

%

(1)

Metric is a non-GAAP Financial Measure. See page 10 for additional information on our use of non-GAAP Financial Measures.

(2)

Metrics include only loans held for investment. Loans held for sale are not included.

Balance Sheet Total assets were $27.7 billion as of December 31, 2024, compared to $28.1 billion at September 30, 2024, primarily due to cash used to reduce borrowings during the quarter. Net loans increased by $144 million, or 0.7%, and cash decreased $873 million, or 36.7%. Investment securities increased by $271 million, or 9.0%, during the quarter.

Customer deposits totaled $21.4 billion as of December 31, 2024, largely unchanged from September 30, 2024. Transaction accounts increased by $37 million or 0.3% during the quarter, while time deposits increased $28 million, also 0.3%. As of December 31, 2024, 55.3% of the Company’s deposits were transaction accounts, unchanged from September 30, 2024. Core deposits, defined as all transaction accounts and time deposits less than $250,000, totaled 78.3% of deposits at December 31, 2024. Deposits that are uninsured or not collateralized were 24.8% as of December 31, 2024, a slight increase from 24.0% as of September 30, 2024.

Borrowings totaled $2.9 billion as of December 31, 2024, down from $3.3 billion at September 30, 2024. The effective weighted average interest rate of borrowings was 3.62% as of December 31, 2024, compared to 3.93% at September 30, 2024.

Loan originations totaled $0.9 billion for the first fiscal quarter of 2025, compared to $0.9 billion of originations in the same quarter one year ago. Offsetting loan originations in each of these quarters were loan repayments of $1.0 billion and $1.2 billion, respectively. The Bank had intentionally slowed new loan production to temper net loan growth. Commercial loans represented 68% of all loan originations during the first fiscal quarter of 2025 and consumer loans accounted for the remaining 32%. Commercial loans are viewed by the Bank as preferable as they generally have floating interest rates and shorter durations. The weighted average period end interest rate on the loan portfolio was 5.16% as of December 31, 2024, a decrease from 5.26% as of September 30, 2024.

Credit Quality Credit quality continues to be monitored closely in light of the shifting economic and monetary environment. As of December 31, 2024, non-performing assets increased slightly to $79 million, or 0.3% of total assets, from $77 million, or 0.3%, at September 30, 2024. The change fiscal year to date is due primarily to non-accrual loans increasing by $2.9 million, or 4%, since September 30, 2024. Delinquent loans were slightly increased at 0.30% of total loans at December 31, 2024, compared to 0.25% at September 30, 2024. The allowance for credit losses (including the reserve for unfunded commitments) totaled $225 million as of December 31, 2024, and was 1.00% of gross loans outstanding, as compared to $225 million, or 1.01% of gross loans outstanding, as of September 30, 2024. Net charge-offs were $231,000 for the first fiscal quarter of 2025, compared to $70,000 for the prior quarter.

Profitability Net interest income was $155 million for the first fiscal quarter of 2025, a decrease of $17.4 million or 10% from the prior quarter. The decrease in net interest income was primarily due to a 36 basis point decrease in the rate earned on interest earning assets offset by a smaller 14 basis point decrease in the average rate paid on interest bearing liabilities. Interest income was also affected by a valuation adjustment to hedges obtained in the Luther Burbank acquisition resulting in a reduction of $3.9 million. Net interest margin was 2.39% in the first fiscal quarter of 2025 compared to 2.62% for the quarter ended September 30, 2024.

Total non-interest income was $15.7 million for the first fiscal quarter of 2025 compared to $15.9 million the prior quarter. The small decrease in other income compared to prior quarter was primarily due to slightly decreased commission income from the Bank’s insurance subsidiary.

Total non-interest expense was $111.3 million in the first fiscal quarter of 2025, an increase of $3.4 million, or 3.1%, from the prior quarter. The overall increase is the result of the $5.4 million of restructuring costs incurred in the quarter offset by a decrease in FDIC premiums of $2.0 million in the same period. Increased expenses combined with decreased net interest income resulted in an increase in the Company’s efficiency ratio in the first fiscal quarter of 2025 to 65.0%, compared to 57.2% in the prior quarter.

The Company is also in the process of restarting its wholly owned technology subsidiary Pike Street Labs and will bring back in-house its custom online, mobile and digital account opening technology and teams from Archway Software. We anticipate this transition will aid us in becoming more efficient over time.

The Company did not record a provision for credit losses in the first fiscal quarter of 2025, consistent with the prior quarter. The lack of provision for loan losses in the quarter ended December 31, 2024 was primarily due to a stable loans receivable balance and stable credit performance.

Return on common shareholders’ equity for the quarter ended December 31, 2024 was 6.42% compared to 8.53% for the quarter ended September 30, 2024. Adjusted for certain non-operating items relating to the merger and restructuring, return on equity for the quarter is 7.45% compared to adjusted return on equity of 8.18% the prior quarter. Return on assets for the quarter ended December 31, 2024 was 0.7% compared to 0.9% for the previous quarter. Adjusted for certain non-operating items relating to the merger and restructuring, return on assets for the quarter is 0.8% compared to adjusted return on equity of 0.8% the prior quarter. For a reconciliation of these adjusted ratios, see the Non-GAAP Financial Measures section below.

Income tax expense totaled $13.0 million the first fiscal quarter of 2025, as compared to $13.2 million for the prior year same quarter. The effective tax rate for the quarter ended December 31, 2024 was 21.55% compared to 24.21% for the quarter ended September 30, 2024. The Company’s effective tax rate may vary from the statutory rate mainly due to state taxes, tax-exempt income and tax-credit investments.

WaFd Bank is headquartered in Seattle, Washington, and has 210 branches in nine western states. To find out more about WaFd Bank, please visit our website www.wafdbank.com. The Company uses its website to distribute financial and other material information about the Company.

 

December 31, 2024

 

September 30, 2024

 

(In thousands, except share and ratio data)

ASSETS

 

 

 

 

 

Cash and cash equivalents

 

$

1,507,735

 

 

 

$

2,381,102

 

Available-for-sale securities, at fair value

 

 

2,743,731

 

 

 

 

2,572,709

 

Held-to-maturity securities, at amortized cost

 

 

537,348

 

 

 

 

436,972

 

Loans receivable, net of allowance for loan losses of $204,522 and $203,753

 

 

21,060,501

 

 

 

 

20,916,354

 

Interest receivable

 

 

103,147

 

 

 

 

102,827

 

Premises and equipment, net

 

 

248,924

 

 

 

 

247,901

 

Real estate owned

 

 

3,316

 

 

 

 

4,567

 

FHLB stock

 

 

128,396

 

 

 

 

95,617

 

Bank owned life insurance

 

 

269,473

 

 

 

 

267,633

 

Intangible assets, including goodwill of $414,722 and $411,360

 

 

449,213

 

 

 

 

448,425

 

Deferred tax assets, net

 

 

111,830

 

 

 

 

119,248

 

Other assets

 

 

520,840

 

 

 

 

466,975

 

 

 

$

27,684,454

 

 

 

$

28,060,330

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

Liabilities

 

 

 

 

 

Transaction deposits

 

$

11,853,859

 

 

 

$

11,817,185

 

Time deposits

 

 

9,584,918

 

 

 

 

9,556,785

 

Total customer deposits

 

 

21,438,777

 

 

 

 

21,373,970

 

Borrowings

 

 

2,863,675

 

 

 

 

3,267,589

 

Junior subordinated debentures

 

 

50,952

 

 

 

 

50,718

 

Advance payments by borrowers for taxes and insurance

 

 

20,188

 

 

 

 

61,330

 

Accrued expenses and other liabilities

 

 

289,226

 

 

 

 

306,423

 

 

 

 

24,662,818

 

 

 

 

25,060,030

 

Shareholders’ equity

 

 

 

 

 

Preferred stock, $1.00 par value, 5,000,000 shares authorized; 300,000 and 300,000 shares issued; 300,000 and 300,000 shares outstanding

 

 

300,000

 

 

 

 

300,000

 

Common stock, $1.00 par value, 300,000,000 shares authorized; 154,247,734 and 154,007,429 shares issued; 81,373,760 and 81,220,269 shares outstanding

 

 

154,248

 

 

 

 

154,007

 

Additional paid-in capital

 

 

2,154,929

 

 

 

 

2,150,675

 

Accumulated other comprehensive income (loss), net of taxes

 

 

53,353

 

 

 

 

55,851

 

Treasury stock, at cost; 72,873,974 and 72,787,160 shares

 

 

(1,642,480

)

 

 

 

(1,639,131

)

Retained earnings

 

 

2,001,586

 

 

 

 

1,978,898

 

 

 

 

3,021,636

 

 

 

 

3,000,300

 

 

 

$

27,684,454

 

 

 

$

28,060,330

 

Weighted average rates as of period end

 

 

 

 

 

Loans and mortgage-backed securities

 

5.06

%

 

 

5.16

%

Combined loans, mortgage-backed securities and investments

 

4.98

 

 

 

5.11

 

Customer accounts

 

2.92

 

 

 

3.09

 

Borrowings

 

3.62

 

 

 

3.93

 

Combined cost of customer accounts and borrowings

 

3.00

 

 

 

3.20

 

Net interest spread

 

1.98

 

 

 

1.91

 

WAFD, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

Three Months Ended December 31,

 

 

2024

 

 

2023

 

(In thousands, except share and ratio data)

INTEREST INCOME

 

 

 

 

 

Loans receivable

 

$

286,597

 

 

$

245,792

Mortgage-backed securities

 

 

18,337

 

 

 

11,266

Investment securities and cash equivalents

 

 

40,183

 

 

 

29,788

 

 

 

345,117

 

 

 

286,846

INTEREST EXPENSE

 

 

 

 

 

Customer accounts

 

 

162,150

 

 

 

96,671

Borrowings and junior subordinated debentures

 

 

27,536

 

 

 

37,938

 

 

 

189,686

 

 

 

134,609

Net interest income

 

 

155,431

 

 

 

152,237

Provision (release) for credit losses

 

 

 

 

 

Net interest income after provision (release)

 

 

155,431

 

 

 

152,237

NON-INTEREST INCOME

 

 

 

 

 

Gain (loss) on sale of investment securities

 

 

20

 

 

 

81

Gain (loss) on termination of hedging derivatives

 

 

5

 

 

 

109

Loan fee income

 

 

1,345

 

 

 

844

Deposit fee income

 

 

7,046

 

 

 

6,802

Other income

 

 

7,286

 

 

 

6,331

Total non-interest income

 

 

15,702

 

 

 

14,167

NON-INTEREST EXPENSE

 

 

 

 

 

Compensation and benefits

 

 

59,927

 

 

 

49,841

Occupancy

 

 

10,788

 

 

 

9,371

FDIC insurance premiums

 

 

4,850

 

 

 

6,570

Product delivery

 

 

5,785

 

 

 

6,009

Information technology

 

 

14,192

 

 

 

12,866

Other expense

 

 

15,769

 

 

 

11,883

Total non-interest expense

 

 

111,311

 

 

 

96,540

Gain (loss) on real estate owned, net

 

 

429

 

 

 

1,826

Income before income taxes

 

 

60,251

 

 

 

71,690

Income tax provision

 

 

12,984

 

 

 

13,237

Net income

 

 

47,267

 

 

 

58,453

Dividends on preferred stock

 

 

3,656

 

 

 

3,656

Net income available to common shareholders

 

$

43,611

 

 

$

54,797

PER SHARE DATA

 

 

 

 

 

Basic earnings per common share

 

$

0.54

 

 

 

$

0.85

 

Diluted earnings per common share

 

 

0.54

 

 

 

 

0.85

 

Cash dividends per common share

 

 

0.26

 

 

 

 

0.25

 

Basic weighted average shares outstanding

 

 

81,294,227

 

 

 

 

64,297,499

 

Diluted weighted average shares outstanding

 

 

81,401,599

 

 

 

 

64,312,110

 

PERFORMANCE RATIOS

 

 

 

 

 

Return on average assets

 

 

0.69

%

 

 

 

1.04

%

Return on average common equity

 

 

6.42

%

 

 

 

10.21

%

 

WAFD, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

Three Months Ended

 

December 31,

2024

 

September 30,

2024

 

June 30,

2024

 

March 31,

2024

 

December 31,

2023

 

 

(In thousands, except share and ratio data)

INTEREST INCOME

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans receivable

 

$

286,597

 

 

$

308,598

 

 

 

$

337,118

 

 

 

$

274,341

 

 

 

$

245,792

Mortgage-backed securities

 

 

18,337

 

 

 

18,088

 

 

 

 

17,523

 

 

 

 

12,905

 

 

 

 

11,266

Investment securities and cash equivalents

 

 

40,183

 

 

 

47,411

 

 

 

 

37,300

 

 

 

 

31,580

 

 

 

 

29,788

 

 

 

345,117

 

 

 

374,097

 

 

 

 

391,941

 

 

 

 

318,826

 

 

 

 

286,846

INTEREST EXPENSE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Customer accounts

 

 

162,150

 

 

 

165,240

 

 

 

 

154,359

 

 

 

 

116,164

 

 

 

 

96,671

Borrowings, senior debt and junior subordinated debentures

 

 

27,536

 

 

 

36,045

 

 

 

 

60,396

 

 

 

 

44,065

 

 

 

 

37,938

 

 

 

189,686

 

 

 

201,285

 

 

 

 

214,755

 

 

 

 

160,229

 

 

 

 

134,609

Net interest income

 

 

155,431

 

 

 

172,812

 

 

 

 

177,186

 

 

 

 

158,597

 

 

 

 

152,237

Provision for credit losses

 

 

 

 

 

 

 

 

 

1,500

 

 

 

 

16,000

 

 

 

 

Net interest income after provision

 

 

155,431

 

 

 

172,812

 

 

 

 

175,686

 

 

 

 

142,597

 

 

 

 

152,237

NON-INTEREST INCOME

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on sale of investment securities

 

 

20

 

 

 

91

 

 

 

 

80

 

 

 

 

90

 

 

 

 

81

Gain on termination of hedging derivatives

 

 

5

 

 

 

72

 

 

 

 

54

 

 

 

 

6

 

 

 

 

109

Loan fee income

 

 

1,345

 

 

 

757

 

 

 

 

594

 

 

 

 

550

 

 

 

 

844

Deposit fee income

 

 

7,046

 

 

 

7,047

 

 

 

 

6,960

 

 

 

 

6,698

 

 

 

 

6,802

Other income

 

 

7,286

 

 

 

7,911

 

 

 

 

9,567

 

 

 

 

6,048

 

 

 

 

6,331

Total non-interest income

 

 

15,702

 

 

 

15,878

 

 

 

 

17,255

 

 

 

 

13,392

 

 

 

 

14,167

NON-INTEREST EXPENSE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Compensation and benefits

 

 

59,927

 

 

 

53,983

 

 

 

 

57,169

 

 

 

 

73,155

 

 

 

 

49,841

Occupancy

 

 

10,788

 

 

 

10,843

 

 

 

 

10,904

 

 

 

 

10,918

 

 

 

 

9,371

FDIC insurance premiums

 

 

4,850

 

 

 

6,800

 

 

 

 

7,600

 

 

 

 

7,900

 

 

 

 

6,570

Product delivery

 

 

5,785

 

 

 

6,306

 

 

 

 

6,090

 

 

 

 

5,581

 

 

 

 

6,009

Information technology

 

 

14,192

 

 

 

14,129

 

 

 

 

13,428

 

 

 

 

12,883

 

 

 

 

12,866

Other expense

 

 

15,769

 

 

 

15,880

 

 

 

 

14,888

 

 

 

 

23,275

 

 

 

 

11,883

Total non-interest expense

 

 

111,311

 

 

 

107,941

 

 

 

 

110,079

 

 

 

 

133,712

 

 

 

 

96,540

Gain (loss) on real estate owned, net

 

 

429

 

 

 

(83

)

 

 

 

(124

)

 

 

 

(1,315

)

 

 

 

1,826

Income before income taxes

 

 

60,251

 

 

 

80,666

 

 

 

 

82,738

 

 

 

 

20,962

 

 

 

 

71,690

Income tax provision

 

 

12,984

 

 

 

19,526

 

 

 

 

18,178

 

 

 

 

5,074

 

 

 

 

13,237

Net income

 

 

47,267

 

 

 

61,140

 

 

 

 

64,560

 

 

 

 

15,888

 

 

 

 

58,453

Dividends on preferred stock

 

 

3,656

 

 

 

3,656

 

 

 

 

3,656

 

 

 

 

3,656

 

 

 

 

3,656

Net income available to common shareholders

 

$

43,611

 

 

$

57,484

 

 

 

$

60,904

 

 

 

$

12,232

 

 

 

$

54,797

WAFD, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

Three Months Ended

 

December 31,

2024

 

September 30,

2024

 

June 30,

2024

 

March 31,

2024

 

December 31,

2023

 

 

(In thousands, except share and ratio data)

PER SHARE DATA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per common share

 

$

0.54

 

 

 

$

0.71

 

 

 

$

0.75

 

 

 

$

0.17

 

 

 

$

0.85

 

Diluted earnings per common share

 

 

0.54

 

 

 

 

0.71

 

 

 

 

0.75

 

 

 

 

0.17

 

 

 

 

0.85

 

Cash dividends per common share

 

 

0.26

 

 

 

 

0.26

 

 

 

 

0.26

 

 

 

 

0.26

 

 

 

 

0.25

 

Basic weighted average shares outstanding

 

 

81,294,227

 

 

 

 

81,208,683

 

 

 

 

81,374,811

 

 

 

 

70,129,072

 

 

 

 

64,297,499

 

Diluted weighted average shares outstanding

 

 

81,401,599

 

 

 

 

81,353,644

 

 

 

 

81,393,708

 

 

 

 

70,164,558

 

 

 

 

64,312,110

 

PERFORMANCE RATIOS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Return on average assets

 

 

0.69

%

 

 

 

0.87

%

 

 

 

0.87

%

 

 

 

0.26

%

 

 

 

1.04

%

Return on average common equity

 

 

6.42

 

 

 

 

8.53

 

 

 

 

9.20

 

 

 

 

2.09

 

 

 

 

10.21

 

Net interest margin

 

 

2.39

 

 

 

 

2.62

 

 

 

 

2.56

 

 

 

 

2.73

 

 

 

 

2.91

 

Efficiency ratio

 

 

65.04

 

 

 

 

57.21

 

 

 

 

56.61

 

 

 

 

77.74

 

 

 

 

58.02

 

 

WAFD, INC. AND SUBSIDIARIES

NON-GAAP MEASURES

(UNAUDITED)

 Non-GAAP Financial Measures

The Company has presented certain non-GAAP measures within this document to remove the effect of certain income and expenses to provide investors with information useful in understanding our financial performance. The Company considers these items to be non-operating in nature as they are items that management does not consider indicative of the Company’s on-going financial performance. We believe that the tables presented reflect our on-going performance in the periods presented and, accordingly, are useful to consider in addition to our GAAP financial results. These measures should not be considered a substitution for GAAP basis disclosures.

Other companies may use similarly titled non-GAAP financial measures that are calculated differently from the way they are calculated herein. Because of this, our non-GAAP financial measures may not be comparable to similar measures used by others. We caution investors not to place undue reliance on such measures. See the following unaudited tables for reconciliations of our non-GAAP measures to the most directly comparable GAAP financial measures.

 

Tangible Measures

December 31,

2024

 

September 30,

2024

 

 

June 30,

2024

 

March 31,

2024

 

December 31,

2023

(Unaudited – In thousands, except for ratio data)

 

Shareholders equity – GAAP

 

$

3,021,636

 

 

$

3,000,300

 

 

$

2,958,339

 

 

$

2,921,906

 

 

$

2,452,004

 

Less intangible assets – GAAP

 

 

449,213

 

 

 

448,425

 

 

 

452,255

 

 

 

453,539

 

 

 

311,103

 

Tangible shareholders’ equity

 

$

2,572,423

 

 

$

2,551,875

 

 

$

2,506,084

 

 

$

2,468,367

 

 

$

2,140,901

 

Less preferred stock – GAAP

 

 

300,000

 

 

 

300,000

 

 

 

300,000

 

 

 

300,000

 

 

 

300,000

 

Tangible common shareholders’ equity

 

$

2,272,423

 

 

$

2,251,875

 

 

$

2,206,084

 

 

$

2,168,367

 

 

$

1,840,901

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets – GAAP

 

$

27,684,454

 

 

$

28,060,330

 

 

$

28,580,800

 

 

$

30,140,288

 

 

$

22,640,122

 

Less intangible assets – GAAP

 

 

449,213

 

 

 

448,425

 

 

 

452,255

 

 

 

453,539

 

 

 

311,103

 

Tangible assets

 

$

27,235,241

 

 

$

27,611,905

 

 

$

28,128,545

 

 

$

29,686,749

 

 

$

22,329,019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tangible Metrics

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common shares outstanding – GAAP

 

 

81,373,760

 

 

 

81,220,269

 

 

 

81,157,173

 

 

 

81,405,391

 

 

 

64,254,700

 

Tangible common equity per share

 

$

27.93

 

 

$

27.73

 

 

$

27.18

 

 

$

26.64

 

 

$

28.65

 

Tangible equity to tangible assets

 

 

9.45

%

 

 

9.24

%

 

 

8.91

%

 

 

8.31

%

 

 

9.59

%

 

WAFD, INC. AND SUBSIDIARIES

NON-GAAP MEASURES

(UNAUDITED)

 

 

 

Three Months Ended

Average Tangible Measures

December 31,

2024

 

September 30,

2024

 

 

June 30,

2024

 

March 31,

2024

 

December 31,

2023

 

(Unaudited – In thousands, except for ratio data)

Average shareholders equity – GAAP

 

$

3,015,197

 

 

$

2,996,093

 

 

$

2,947,056

 

 

$

2,638,483

 

 

$

2,447,580

 

Less average preferred stock

– GAAP

 

 

300,000

 

 

 

300,000

 

 

 

300,000

 

 

 

300,000

 

 

 

300,000

 

Less average intangible assets – GAAP

 

 

447,754

 

 

 

451,204

 

 

 

453,142

 

 

 

360,251

 

 

 

311,022

 

Average tangible common equity

 

$

2,267,443

 

 

$

2,244,889

 

 

$

2,193,914

 

 

$

1,978,232

 

 

$

1,836,558

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Assets – GAAP

 

$

27,504,576

 

 

$

28,000,482

 

 

$

29,703,337

 

 

$

24,907,376

 

 

$

22,381,459

 

Less average intangible assets – GAAP

 

 

447,754

 

 

 

451,204

 

 

 

453,142

 

 

 

360,251

 

 

 

311,022

 

Average tangible assets

 

$

27,056,822

 

 

$

27,549,278

 

 

$

29,250,195

 

 

$

24,547,125

 

 

$

22,070,437

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Tangible Metrics

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income – GAAP

 

 

47,267

 

 

 

61,140

 

 

 

64,560

 

 

 

15,888

 

 

 

58,453

 

Net income available to common shareholders – GAAP

 

 

43,611

 

 

 

57,484

 

 

 

60,904

 

 

 

12,232

 

 

 

54,797

 

Return on tangible common equity

 

 

7.69

%

 

 

10.24

%

 

 

11.10

%

 

 

2.47

%

 

 

11.93

%

Return on tangible assets

 

 

0.70

%

 

 

0.89

%

 

 

0.88

%

 

 

0.26

%

 

 

1.06

%

WAFD, INC. AND SUBSIDIARIES

NON-GAAP MEASURES

(UNAUDITED)

 

 

 

Three Months Ended

Net Income Adjusted for Acquisition Expenses and Other Non-Operating Items

December 31,

2024

 

September 30,

2024

 

 

June 30,

2024

 

March 31,

2024

 

December 31,

2023

 

(Unaudited – In thousands, except for ratio data)

Interest income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LBC Hedge Valuation Adj

 

$

3,933

 

 

 

$

 

 

 

$

 

 

 

$

 

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-interest income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Distribution received on LBC equity method investment

 

$

(279

)

 

 

$

(288

)

 

 

$

(299

)

 

 

$

(287

)

 

 

$

 

(Gain)Loss on WaFd Bank equity method investment

 

 

48

 

 

 

 

(896

)

 

 

 

(748

)

 

 

 

2,195

 

 

 

 

693

 

Total non-interest income

 

$

(231

)

 

 

$

(1,184

)

 

 

$

(1,047

)

 

 

$

1,908

 

 

 

$

693

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-interest expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition-related expenses

 

$

239

 

 

 

$

(1,602

)

 

 

$

2,285

 

 

 

$

25,120

 

 

 

$

516

 

Non-operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring Charges

 

 

5,390

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FDIC Special Assessment

 

 

 

 

 

 

(216

)

 

 

 

 

 

 

 

1,800

 

 

 

 

500

 

Legal and Compliance

 

 

 

 

 

 

(182

)

 

 

 

 

 

 

 

3,000

 

 

 

 

 

Charitable Donation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,000

 

 

 

 

 

 

 

 

5,390

 

 

 

 

(398

)

 

 

 

 

 

 

 

6,800

 

 

 

 

500

 

Total non-interest expense

 

$

5,629

 

 

 

$

(2,000

)

 

 

$

2,285

 

 

 

$

31,920

 

 

 

$

1,016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income – GAAP

 

$

47,267

 

 

 

$

61,140

 

 

 

$

64,560

 

 

 

$

15,888

 

 

 

$

58,453

 

Preliminary ACL provision on LBC loans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

16,000

 

 

 

 

 

Interest income adjustments

 

 

3,933

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-interest income adjustments

 

 

(231

)

 

 

 

(1,184

)

 

 

 

(1,047

)

 

 

 

1,908

 

 

 

 

693

 

Non-interest expense adjustments

 

 

5,629

 

 

 

 

(2,000

)

 

 

 

2,285

 

 

 

 

31,920

 

 

 

 

1,016

 

REO adjustments

 

 

(429

)

 

 

 

83

 

 

 

 

124

 

 

 

 

1,315

 

 

 

 

(1,826

)

Income tax adjustment

 

 

(1,918

)

 

 

 

751

 

 

 

 

(299

)

 

 

 

(12,274

)

 

 

 

22

 

Net Income – non-GAAP

 

$

54,251

 

 

 

$

58,790

 

 

 

$

65,623

 

 

 

$

54,757

 

 

 

$

58,358

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividend on preferred stock

 

 

3,656

 

 

 

 

3,656

 

 

 

 

3,656

 

 

 

 

3,656

 

 

 

 

3,656

 

Net Income available to common shareholders – non-GAAP

 

$

50,595

 

 

 

$

55,134

 

 

 

$

61,967

 

 

 

$

51,101

 

 

 

$

54,702

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average number

 

 

81,294,227

 

 

 

 

81,208,683

 

 

 

 

81,374,811

 

 

 

 

70,129,072

 

 

 

 

64,297,499

 

Diluted weighted average

 

 

81,401,599

 

 

 

 

81,353,644

 

 

 

 

81,393,708

 

 

 

 

70,164,558

 

 

 

 

64,312,110

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic EPS – non-GAAP

 

$

0.62

 

 

 

$

0.68

 

 

 

$

0.76

 

 

 

$

0.73

 

 

 

$

0.84

 

Diluted EPS – non-GAAP

 

 

0.62

 

 

 

 

0.68

 

 

 

 

0.76

 

 

 

 

0.73

 

 

 

 

0.84

 

WAFD, INC. AND SUBSIDIARIES

NON-GAAP MEASURES

(UNAUDITED)

 

 

 

Three Months Ended

 

Adjusted Efficiency Ratio

December 31,

2024

September 30,

2024

 

June 30,

2024

March 31,

2024

 

December 31,

2023

 

(Unaudited – In thousands, except for ratio data)

 

Efficiency ratio – GAAP

 

 

65.0

%

 

 

57.2

%

 

 

56.6

%

 

 

77.7

%

 

 

58.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Net interest income – GAAP

 

$

155,431

 

 

$

172,812

 

 

$

177,186

 

 

$

158,597

 

 

$

152,237

 

Total interest income adjustments

 

 

3,933

 

 

 

 

 

 

 

 

 

 

 

 

 

Net interest income – non-GAAP

 

$

159,364

 

 

$

172,812

 

 

$

177,186

 

 

$

158,597

 

 

$

152,237

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-interest expense – GAAP

 

$

111,311

 

 

$

107,941

 

 

$

110,079

 

 

$

133,712

 

 

$

96,540

 

Less merger related expenses

 

 

239

 

 

 

(1,602

)

 

 

2,285

 

 

 

25,120

 

 

 

516

 

Less non-operating expenses

 

 

5,390

 

 

 

(398

)

 

 

 

 

 

6,800

 

 

 

500

 

Non-interest Expenses –

non-GAAP

 

$

105,682

 

 

$

109,941

 

 

$

107,794

 

 

$

101,792

 

 

$

95,524

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-interest income – GAAP

 

$

15,702

 

 

$

15,878

 

 

$

17,255

 

 

$

13,392

 

 

$

14,167

 

Total other income

 

 

(231

)

 

 

(1,184

)

 

 

(1,047

)

 

 

1,908

 

 

 

693

 

Non-interest income –

non-GAAP

 

$

15,471

 

 

$

14,694

 

 

$

16,208

 

 

$

15,300

 

 

$

14,860

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Interest Income –

non-GAAP

 

$

159,364

 

 

$

172,812

 

 

$

177,186

 

 

$

158,597

 

 

$

152,237

 

Non-interest income –

non-GAAP

 

 

15,471

 

 

 

14,694

 

 

 

16,208

 

 

 

15,300

 

 

 

14,860

 

Total Income – non-GAAP

 

$

174,835

 

 

$

187,506

 

 

$

193,394

 

 

$

173,897

 

 

$

167,097

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Efficiency Ratio

 

 

60.4

%

 

 

58.6

%

 

 

55.7

%

 

 

58.5

%

 

 

57.2

%

WAFD, INC. AND SUBSIDIARIES

NON-GAAP MEASURES

(UNAUDITED)

 

 

 

Three Months Ended

 

Adjusted ROA and ROE

December 31,

2024

 

September 30,

2024

 

 

June 30,

2024

 

March 31,

2024

 

December 31,

2023

 

(Unaudited – In thousands, except for ratio data)

 

Reported:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income – GAAP

 

$

47,267

 

 

$

61,140

 

 

$

64,560

 

 

$

15,888

 

 

$

58,453

 

Net income available to common shareholders – GAAP

 

$

43,611

 

 

$

57,484

 

 

$

60,904

 

 

$

12,232

 

 

$

54,797

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Assets

 

 

27,504,576

 

 

 

28,000,482

 

 

 

29,703,337

 

 

 

24,907,376

 

 

 

22,381,459

 

Return on Assets

 

 

0.69

%

 

 

0.87

%

 

 

0.87

%

 

 

0.26

%

 

 

1.04

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Common Equity

 

$

2,715,197

 

 

$

2,696,093

 

 

$

2,647,056

 

 

$

2,338,483

 

 

$

2,147,580

 

Return on common equity

 

 

6.42

%

 

 

8.53

%

 

 

9.20

%

 

 

2.09

%

 

 

10.21

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income – non-GAAP

 

$

54,251

 

 

$

58,790

 

 

$

65,623

 

 

$

54,757

 

 

$

58,358

 

Net income available to common shareholders – non-GAAP

 

$

50,595

 

 

$

55,134

 

 

$

61,967

 

 

$

51,101

 

 

$

54,702

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Assets

 

 

27,504,576

 

 

 

28,000,482

 

 

 

29,703,337

 

 

 

24,907,376

 

 

 

22,381,459

 

Adjusted Return on Assets

 

 

0.79

%

 

 

0.84

%

 

 

0.88

%

 

 

0.88

%

 

 

1.04

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Common Equity

 

 

2,715,197

 

 

 

2,696,093

 

 

 

2,647,056

 

 

 

2,338,483

 

 

 

2,147,580

 

Adjusted Return on common equity

 

 

7.45

%

 

 

8.18

%

 

 

9.36

%

 

 

8.74

%

 

 

10.19

%

Important Cautionary Statements

The foregoing information should be read in conjunction with the financial statements, notes and other information contained in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

This press release contains statements about the Company’s future that are not statements of historical or current fact. These statements are “forward-looking statements” for purposes of applicable securities laws and are based on current information and/or management’s good faith belief as to future events. Words such as “expects,” “anticipates,” “believes,” “estimates,” “intends,” “forecasts,” “may,” “potential,” “projects,” and other similar expressions or future or conditional verbs such as “will,” “should,” “would,” and “could” are intended to help identify such forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the Company believes any such statements are based on reasonable assumptions, forward-looking statements should not be read as a guarantee of future performance, and you are cautioned not to place undue reliance on any forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statement.

By their nature, forward-looking statements involve inherent risk and uncertainties including the following risks and uncertainties, and those risks and uncertainties more fully discussed under “Risk Factors” in the Company’s September 30, 2024 10-K, and Quarterly Reports on Form 10-Q which could cause actual performance to differ materially from that anticipated by any forward-looking statements. Forward-looking statements relating to our financial condition or operations are subject to risks and uncertainties related to (i) fluctuations in interest rate risk and market interest rates, including the effect on our net interest income and net interest margin; (ii) current and future economic conditions, including the effects of declines in the real estate market, high unemployment rates, inflationary pressures, a potential recession, the monetary policies of the Federal Reserve, and slowdowns in economic growth either nationally or locally in some or all of the areas in which we conduct business; (iii) financial stress on borrowers (consumers and businesses) as a result of higher interest rates or an uncertain economic environment; (iv) changes in deposit flows or loan demands; (v) our ability to identify and address cyber-security risks, including security breaches, “denial of service attacks,” “hacking” and identity theft; (vi) the Company’s exit from the mortgage lending business; (vii) the effects of natural or man-made disasters, calamities, or conflicts, including terrorist events and pandemics (such as the COVID-19 pandemic) and the resulting governmental and societal responses; (viii) the results of examinations by regulatory authorities, including a “Needs to Improve” CRA rating, which may impose restrictions or penalties on the Company’s activities; (ix) expectations regarding key growth initiatives and strategic priorities; (x) global economic trends, including developments related to Ukraine and Russia, and the evolving conflict in the Middle East, and related negative financial impacts on our borrowers; (xi) litigation risks resulting in significant expenses, losses and reputational damage; (xii) the impact of bank failures or adverse developments at other banks and related negative press about regional banks and the banking industry in general; and (xiii) other economic, competitive, governmental, environmental, regulatory, and technological factors affecting our operations, pricing, products and services.

WaFd, Inc.

425 Pike Street, Seattle, WA 98101

Brad Goode, SVP, Chief Marketing Officer

206-626-8178

[email protected]

 

KEYWORDS: Idaho Oregon Washington Utah New Mexico Texas Arizona Nevada United States North America

INDUSTRY KEYWORDS: Finance Banking Professional Services Asset Management Fintech

MEDIA:

Logo
Logo

EPR Properties Fourth Quarter and Year End 2024 Earnings Conference Call Scheduled for February 27, 2025

EPR Properties Fourth Quarter and Year End 2024 Earnings Conference Call Scheduled for February 27, 2025

KANSAS CITY, Mo.–(BUSINESS WIRE)–
EPR Properties (NYSE: EPR) announced today that the Company will release its fourth quarter 2024 financial results after the market close on Wednesday, February 26, 2025 at approximately 4:15 p.m. ET. Management will host a conference call to discuss the Company’s financial results on Thursday, February 27, 2025 at 8:30 a.m. ET.

The conference call will be webcast and can be accessed via the Webcasts page in the Investor Center on the Company’s website located at http://investors.eprkc.com/webcasts. It is recommended that you join 10 minutes prior to the event start (although you may register and join the webcast at any time).

You may watch a replay of the webcast by visiting the Webcasts page at http://investors.eprkc.com/webcasts.

About EPR Properties

EPR Properties (NYSE:EPR) is the leading diversified experiential net lease real estate investment trust (REIT), specializing in select enduring experiential properties in the real estate industry. We focus on real estate venues that create value by facilitating out of home leisure and recreation experiences where consumers choose to spend their discretionary time and money. We have total assets of approximately $5.7 billion (after accumulated depreciation of approximately $1.5 billion) across 44 states. We adhere to rigorous underwriting and investing criteria centered on key industry, property and tenant level cash flow standards. We believe our focused approach provides a competitive advantage and the potential for stable and attractive returns. Further information is available at www.eprkc.com.

EPR Properties

Brian Moriarty

Senior Vice President – Corporate Communications

[email protected] | 816-472-1700

KEYWORDS: Missouri United States North America

INDUSTRY KEYWORDS: Residential Building & Real Estate Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo

Retail Opportunity Investments Corp. Announces Tax Reporting Information for 2024 Distributions

SAN DIEGO, Jan. 16, 2025 (GLOBE NEWSWIRE) — Retail Opportunity Investments Corp. (NASDAQ: ROIC), announced today the federal tax treatment of the 2024 distributions on its shares of common stock. The federal tax treatment of the 2024 distributions as it is expected to be reported on Form 1099-DIV is as follows:

Record Date Payable Date Total Distribution per Share Ordinary Income per Share Section 199A Dividends1 Total Capital Gain per Share Section 1250 Recapture per Share2
             
03/15/2024 04/05/2024 $0.1500 $0.10140 $0.10140 $0.04860 $0.01943
06/14/2024 07/10/2024 $0.1500 $0.10140 $0.10140 $0.04860 $0.01943
09/20/2024 10/04/2024 $0.1500 $0.10140 $0.10140 $0.04860 $0.01943
12/20/2024 01/10/2025 $0.1500 $0.10140 $0.10140 $0.04860 $0.01943
             

1 Represents dividends eligible for the 20% qualified business income deduction under Section 199A, and is included in “Ordinary Income Per Share”
2 Represents additional characterization of, and is included in, “Total Capital Gain per Share”

Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of ROIC’s distributions.

ABOUT RETAIL OPPORTUNITY INVESTMENTS CORP.

Retail Opportunity Investments Corp. (NASDAQ: ROIC), is a fully-integrated, self-managed real estate investment trust (REIT) that specializes in the acquisition, ownership and management of grocery-anchored shopping centers located in densely-populated, metropolitan markets across the West Coast. As of September 30, 2024, ROIC owned 93 shopping centers encompassing approximately 10.5 million square feet. ROIC is the largest publicly-traded, grocery-anchored shopping center REIT focused exclusively on the West Coast. ROIC is a member of the S&P SmallCap 600 Index and has investment-grade corporate debt ratings from Moody’s Investor Services, S&P Global Ratings, and Fitch Ratings, Inc. Additional information is available at: www.roireit.net.

When used herein, the words “believes,” “anticipates,” “projects,” “should,” “estimates,” “expects,” “guidance” and similar expressions are intended to identify forward-looking statements with the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and in Section 21F of the Securities and Exchange Act of 1934, as amended. Certain statements contained herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results of ROIC to differ materially from future results expressed or implied by such forward-looking statements. Information regarding such risks and factors is described in ROIC’s filings with the SEC, including its most recent Annual Report on Form 10-K, which is available at: www.roireit.net.

Contact:

Nicolette O’Leary, Investor Relations
858-677-0900
[email protected]



Illuccix® Receives European Approval

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 17, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive decision on the Marketing Authorization Application (MAA) for its prostate cancer PET1 imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection), which was submitted in Europe via a decentralized procedure (DCP).

This significant milestone follows the issuance of the Final Assessment Report from the German Competent Authority BfArM2 as Reference Member State (RMS). Through the DCP, the RMS and all 18 European Economic Area (EEA) Concerned Member States (CMS)3 agree that Illuccix should receive marketing authorization. The DCP regulatory process will now transition into an administrative national phase to implement authorizations to facilitate commercial launch in each country4.

Kevin Richardson, Chief Executive Officer, Telix Precision Medicine commented, “We are delighted by this positive outcome, setting the stage for a European commercial launch of Illuccix. This clinically important prostate cancer imaging modality is currently recommended in international clinical practice guidelines including European Association of Urology (EAU) and European Society for Medical Oncology (ESMO).”

PSMA-PET imaging5 represents a major advancement in prostate cancer management, largely replacing conventional imaging methods (bone scan, CT6 scan) as the standard of care after initial diagnosis and biochemical recurrence (BCR). European guidelines highlight the superior accuracy of PSMA-PET for the staging of primary disease7 and evaluation of BCR/biochemical persistence (BCP)8.

About Illuccix®

Telix’s lead imaging product, gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)9, by the Australian Therapeutic Goods Administration (TGA) 10, and by Health Canada11.

In Europe, Illuccix, after radiolabelling with gallium-68, will be indicated for detection of PSMA-positive lesions with PET in adults with prostate cancer (PCa) in the following clinical settings:

  • Primary staging of patients with high-risk PCa prior to primary curative therapy
  • Suspected recurrent PCa in patients with increasing levels of serum prostate-specific antigen (PSA) after primary curative therapy
  • Identification of patients with PSMA-positive progressive metastatic castration-resistant prostate cancer (mCRPC) for whom PSMA-targeted therapy is indicated.

About
Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and SEC filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on X and LinkedIn.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: [email protected]

This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board.

Legal Notices

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

©2025 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals® and Illuccix® names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved.

1 Positron emission tomography.
2 The German Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte).
3 Germany serves as the Reference Member State in the Decentralised Procedure. The other 18 Concerned Member States are Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Luxembourg, Malta, Netherlands, Norway, Portugal, Slovakia, Spain, and Sweden.
4 Regulatory approval timeframe from EEA CMSs may vary considerably.
5 Imaging of prostate-specific membrane antigen with positron emission tomography.
6 Computed tomography.
7 EAU, ESMO.
8 EAU.
9 Telix ASX disclosure 20 December 2021.
10 Telix ASX disclosure 2 November 2021.
11 Telix ASX disclosure 14 October 2022.